sharon sanders
Editor-in-Chief & President
New Malaria Recommendations for Greece
http://www.cdc.gov/malaria/malariagreece.htmThe Centers for Disease Control and Prevention (CDC) has received updated information on malaria cases in Greece. According to a recent publication by Greek health authorities [K Danis, A Baka, A Lenglet, W Van Bortel, et al. Autochthonous Plasmodium vivax malaria in Greece, 2011. Eurosurveillance. 2011 Oct 20, 16(42)], since September 27, 2011, a total of 20 malaria cases have been reported in persons with no history of travel to a malaria-endemic area. An additional 16 cases have been identified in persons from malaria endemic countries in whom importation versus local transmission of malaria could not be determined.
All cases were confirmed to be P vivax. The majority (20 cases) occurred in the southern region of the country, specifically in the Laconia district in the south. Other cases occurred in the Evia/Euboea (island east of the Central Greece region), Eastern Attiki, Voitia, and Larissa districts (see map below).
All cases were confirmed to be P vivax. The majority (20 cases) occurred in the southern region of the country, specifically in the Laconia district in the south. Other cases occurred in the Evia/Euboea (island east of the Central Greece region), Eastern Attiki, Voitia, and Larissa districts (see map below).
K Danis, A Baka, A Lenglet, W Van Bortel, et al. Autochthonous Plasmodium vivax malaria in Greece, 2011. Eurosurveillance. 2011 Oct 20, 16(42).
The Hellenic CDC of Greece continues to work with the European CDC and has responded by enhancing its surveillance system and intensifying mosquito control in affected areas, raising awareness among healthcare providers and hospitals about early malaria diagnosis and treatment, and educating the public about prevention of mosquito bites.
Because of the ongoing evidence of malaria transmission in Laconia district, CDC is recommending that travelers to Laconia district in Greece take anti-malarial medicines to prevent malaria. Recommended antimalarials include one of the following: atovaquone-proguanil (Malarone ?), chloroquine, doxycycline, mefloquine, or primaquine. Note that primaquine is contraindicated in people with glucose-6-phosphate dehydrogenase (G6PD) deficiency. If primaquine is chosen, the traveler must be screened for G6PD deficiency prior to use.
For the districts of Evia/Euboea, Eastern Attiki, Voitia, and Larissa, anti-malarials are not recommended at this time because there have only been a limited number of cases.
Measures to prevent mosquito bites should also be taken for all of these districts with malaria. These measures include using insect repellent when outdoors, and staying in an air-conditioned or well-screened area, or sleeping under an insecticide treated bed net during the peak biting period for mosquitoes (dusk and dawn).
This notice will be updated as new information becomes available.
See the CDC Malaria website for additional health information about malaria including prevention of mosquito bites and drugs used to prevent malaria. For general health information for travelers to all areas of the world, see the CDC Traveler's Health website.
The Hellenic CDC of Greece continues to work with the European CDC and has responded by enhancing its surveillance system and intensifying mosquito control in affected areas, raising awareness among healthcare providers and hospitals about early malaria diagnosis and treatment, and educating the public about prevention of mosquito bites.
Because of the ongoing evidence of malaria transmission in Laconia district, CDC is recommending that travelers to Laconia district in Greece take anti-malarial medicines to prevent malaria. Recommended antimalarials include one of the following: atovaquone-proguanil (Malarone ?), chloroquine, doxycycline, mefloquine, or primaquine. Note that primaquine is contraindicated in people with glucose-6-phosphate dehydrogenase (G6PD) deficiency. If primaquine is chosen, the traveler must be screened for G6PD deficiency prior to use.
For the districts of Evia/Euboea, Eastern Attiki, Voitia, and Larissa, anti-malarials are not recommended at this time because there have only been a limited number of cases.
Measures to prevent mosquito bites should also be taken for all of these districts with malaria. These measures include using insect repellent when outdoors, and staying in an air-conditioned or well-screened area, or sleeping under an insecticide treated bed net during the peak biting period for mosquitoes (dusk and dawn).
This notice will be updated as new information becomes available.
See the CDC Malaria website for additional health information about malaria including prevention of mosquito bites and drugs used to prevent malaria. For general health information for travelers to all areas of the world, see the CDC Traveler's Health website.